HESTER BIOSCIENCES
|
The Current P/E Ratio of HESTER BIOSCIENCES is 34.73.
| Share Price | ₹1,597.0 | Dec 23,2025 |
| Market Cap | ₹1,357.5 Cr | |
| Earnings-TTM | ₹39.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 34.73x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of HESTER BIOSCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,357.5 Cr] as on Dec 23,2025
(/) Earnings [ ₹39.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 34.73x ]
Thus, for HESTER BIOSCIENCES , the investors are currently willing to pay 34.73 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of HESTER BIOSCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of HESTER BIOSCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of HESTER BIOSCIENCES
PE Ratio Performance Analysis for HESTER BIOSCIENCES
- HESTER BIOSCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 51.21x.
- HESTER BIOSCIENCES 's operated at median p/e ratio of 48.58x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HESTER BIOSCIENCES 's p/e ratio peaked in Mar2024 at 62.57x.
- HESTER BIOSCIENCES 's p/e ratio hit its five-year low in Mar2025 of 38.81x.
How does HESTER BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| HESTER BIOSCIENCES | 39.09 | 34.73 | 1,357.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 40.04 | 421,131.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 69.16 | 171,862.0 |
| CIPLA LTD | 5,453.86 | 22.22 | 121,198.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.40 | 129,254.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.72 | 107,083.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.10 | 92,070.0 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.78 | 93,388.6 |
| LUPIN LTD | 4,347.53 | 22.20 | 96,535.3 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.50 | 70,671.9 |
| ABBOTT INDIA LTD | 1,508.95 | 39.91 | 60,221.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs HESTER BIOSCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.72x |
| Max industry PE | 69.16x |
| Median industry PE | 34.73x |
| Average industry PE | 36.25x |
You may also like the below Video Courses